Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
In the last 90 days, Lipocine Inc. insiders filed 3 open-market purchases and 0 sales; 37 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 13, 2026
- $18.9M
- Insider buysLast 90 days, $161.7K in total
- 3
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −10 vs. previous quarter
- 37
- 13F valueReported value at the end of Q2 2026
- $7.63M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $1.98M
- −82.3% year over year
- Net income, FY2025
- -$9.63M
- −115,371.9% year over year
- Free cash flow, FY2025
- –
- No comparable prior period
- Revenue, Q3 FY2026
- $2.29M
- +1,898.8% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $9.63M (487.1% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 325.4K
- Shares sold short
- Change
- −26.0K
- −7.4% vs. previous
- Days to cover
- 1.50
- At average daily volume
Superinvestors holding LPCN, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding LPCN at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Lipocine Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2026 (view filing)3:23 PM ET | Nov 12-13 | 1 day | Patel Mahesh V.Chief Executive Officer | PPurchase | +50.0K | $1.59 | +$79.5K | +31.0%211.5K after | 2 lots |
| Oct 1, 2026 (view filing)8:28 PM ET | Sep 29-30 | 2 days | Higuchi John W.Director | PPurchase | +25.0K | $2.20 | +$55.0K | +11.6%241.4K after | 2 lots |
| Sep 30, 2026 (view filing)8:38 PM ET | Sep 28 | 2 days | Higuchi John W.Director | PPurchase | +12.6K | $2.16 | +$27.1K | +6.2%216.4K after | |
| Apr 7, 2026 (view filing) | Apr 7 | Same day | Higuchi John W.Director | PPurchase | +40.0K | $2.03 | +$81.2K | +24.4%203.8K after | |
| Apr 6, 2026 (view filing) | Apr 6 | Same day | Higuchi John W.Director | PPurchase | +123.0K | $2.05 | +$252.2K | +301.5%163.8K after | |
| Apr 6, 2026 (view filing) | Apr 6 | Same day | Patel Mahesh V.Chief Executive Officer | PPurchase | +25.0K | $2.03 | +$50.8K | +18.4%160.7K after | |
| Apr 2, 2026 (view filing) | Apr 2 | Same day | Patel Mahesh V.Chief Executive Officer | PPurchase | +25.0K | $2.02 | +$50.5K | +22.6%135.7K after | |
| May 25, 2023 (view filing) | May 25 | Same day | Patel Mahesh V.CEO and President | PPurchase | +8.71K | $5.03 | +$43.8K | +8.8%107.4K after | |
| Mar 24, 2023 (view filing)5:28 PM ET | Mar 24 | Same day | Patel Mahesh V.CEO and President | PPurchase | +150.0K | $0.32 | +$48.0K | +9.8%1.68M after | |
| Mar 20, 2023 (view filing)6:51 PM ET | Mar 20 | Same day | Ono Richard DanaDirector | PPurchase | +4.00K | $0.34 | +$1.36K | +39.5%14.1K after |
Top 10 13F holders, Q2 2026
See all 37 holdersThe largest institutional positions in Lipocine Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Squadron Capital Management LLC | 810,000 | $2.07M | 0.71% | +360,000+80.0% | Added |
| Ikarian Capital, LLC | 508,556 | $1.30M | 0.21% | 00.0% | Unchanged |
| Eversept Partners, LP | 294,989 | $755.2K | 0.04% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 230,823 | $590.9K | 0.00% | +30,155+15.0% | Added |
| Acadian Asset Management LLC | 170,417 | $435.0K | 0.00% | +170,417 | New |
| Boothbay Fund Management, LLC | 140,487 | $359.6K | 0.01% | 00.0% | Unchanged |
| Jane Street Group, LLC | 95,227 | $243.8K | 0.00% | +75,200+375.5% | Added |
| BlackRock, Inc. | 89,272 | $228.5K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 84,887 | $217.3K | 0.00% | +51,137+151.5% | Added |
| Citadel Advisors LLC | 81,221 | $207.9K | 0.00% | +52,133+179.2% | Added |
Holders of 5% or more of LPCN
See all 2 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Lipocine Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Squadron Capital Management LLC | 13G/A | 9.80%810.0K shares | +3.60 ppfrom 6.20% | Dec 23, 20254 filings | Aug 14, 2026 | SEC |
| Ikarian Capital, LLC | 13G | 6.30%508.6K shares | New | May 15, 20261 filing | May 15, 2026 | SEC |